Enzyme Commission Number
EC 1.2.1.2
Product Overview
The product exhibiting the specified enzyme activity, was briefly isolated and purified from genetically modified E. coli. Genetic modifications (e.g. CRISPR/Cas9 System) through gene deletions, allele replacements, and the insertion of new genetic materials have been successfully used to create strains with better fermentation dynamics and stress tolerance.
Features
Ready-to-use product, accelerating research progress, enhancing application performance.
Synonyms
formate-NAD oxidoreductase; FDH I; FDH II; N-FDH; formic hydrogen-lyase; formate hydrogenlyase; hydrogenlyase; NAD-linked formate dehydrogenase; NAD-dependent formate dehydrogenase; formate dehydrogenase (NAD); NAD-formate dehydrogenase; formate benzyl-viologen oxidoreductase; formic acid dehydrogenase
Applications
Research Use; Pharmaceutical Industry
Storage
Store at −20°C or colder.
Instruction
Avoid inhalation during use, prevent contact with skin or mucous membranes, and rinse with water immediately after accidental contact.
Enzyme Class
Oxidoreductases
Production Methods
Recombinant Production
Shipping
Timely shipping by optional means
Reaction
formate + NAD+ = CO2 + NADH
Recommendation
Molecular biology and biochemistry research tool
Specification
Standard and Custom Specifications
